Guillermina Ferro-Flores

26PUBLICATIONS
45CO-AUTHORS
Pharmaceutical delivery technologiesRadiation therapyAcceleratorsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 15, 2026
[225Ac]Ac-iPSMA Radiopharmaceuticals for Targeted Alpha Therapy: Design, Synthesis, and Preclinical Evaluation.

|Dec 30, 2025
Enhancing Cytosolic Internalization of [177Lu]Lu-iPSMA in Prostate Cancer Cells: The Effect of Conjugating a GRP78 Inhibitor to the Radiotherapeutic Molecule.

Erika Azorín-Vega, Daniel García-Arce, Myrna Luna-Gutiérrez

|Sep 16, 2025
Assessment of the impact of the nuclear properties ofβ--emitting radionuclides on the dosimetry of two radiopharmaceuticals with distinct pharmacokinetics.

Laura De Nardo, Samuele De Zan, Kevin J H Allen

|Jul 30, 2025
Synthesis and Evaluation of [18F]AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [177Lu]Lu-DOTA-iPD-L1.

Guillermina Ferro-Flores, Myrna Luna-Gutiérrez, Blanca Ocampo-García

|Jul 29, 2025
Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose.

Guillermina Ferro-Flores, Erika Azorín-Vega, Blanca Ocampo-García

|Nov 27, 2024
Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study.

Sofía González-Rueda, Osvaldo García-Pérez, Myrna Luna-Gutiérrez

Pageof 5

Frequent Collaborators

22 joint publications

Blanca Ocampo-García

15 joint publications

Clara Santos-Cuevas

14 joint publications

Myrna Luna-Gutiérrez

11 joint publications

Erika Azorín-Vega